|By PR Newswire||
|March 24, 2014 09:39 PM EDT||
SAN DIEGO and MENLO PARK, Calif., March 24, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Geron Corporation (NASDQ: GERN) has filed a federal securities fraud class action complaint in the U.S. District Court for the Northern District of California. The complaint alleges that the company and certain of its officers and directors violated the Securities and Exchange Act of 1934 between June 16, 2013 and March 11, 2014 (the "Class Period"). Geron is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignanciesis.
Geron Accused of Failing to Disclose Risks Associated with Imetelstat
According to the complaint, shares of Geron fell $2.71 or nearly 61%, to close at $1.69 per share on March 12, 2014, following an announcement by the company that it received notice from the U.S. Food and Drug Administration that its Investigational New Drug application for Imetelstat had been placed on full clinical hold. According to the press release, the FDA's notice resulted from "the occurrence of persistent low-grade liver function test (LFT) abnormalities observed in the Phase 2 study of imetelstat in ET/PV patients and the potential risk of chronic liver injury following long-term exposure to imetelstat." Geron received news of the full clinical hold in the form of a verbal notice from the FDA, which affects all active company-sponsored clinical trials.
The complaint further alleges that Geron failed to disclose to investors the persistent LFT abnormalities observed in the Phase 2 study and the potential risk of chronic liver injury associated with long-term exposure to imetelstat. As a result, Geron statements regarding financial performance were materially false and misleading throughout the Class Period.
Geron Investors Are Encouraged to Contact Shareholder Rights Law Firm Robbins Arroyo
If you invested in Geron and would like to discuss your shareholder rights, please contact attorney Darnell R. Donahue at (800) 350-6003, [email protected], or via the information form on the firm's shareholder rights blog: www.robbinsarroyo.com/shareholders-rights-blog/geron-corporation
Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.
Attorney Advertising. Past results do not guarantee a similar outcome.
SOURCE Robbins Arroyo LLP
SYS-CON Events announced today that Cloudian, Inc., the leading provider of hybrid cloud storage solutions, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Cloudian, Inc., is a Foster City, California - based software company specializing in cloud storage software. The main product is Cloudian, an Amazon S3-compliant cloud object storage platform, the bedrock of cloud computing systems, that enables c...
Dec. 28, 2014 08:30 AM EST Reads: 1,369
The 3rd International Internet of @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that its Call for Papers is now open. The Internet of Things (IoT) is the biggest idea since the creation of the Worldwide Web more than 20 years ago.
Dec. 28, 2014 08:30 AM EST Reads: 2,233
Dec. 28, 2014 08:00 AM EST Reads: 2,726
Dec. 28, 2014 05:45 AM EST Reads: 2,303
Dec. 28, 2014 05:30 AM EST Reads: 1,920
Dec. 28, 2014 05:30 AM EST Reads: 1,879
Dec. 28, 2014 04:00 AM EST Reads: 2,507
Dec. 28, 2014 03:45 AM EST Reads: 2,809
Dec. 28, 2014 03:30 AM EST Reads: 2,595
Dec. 28, 2014 03:00 AM EST Reads: 2,087
Dec. 27, 2014 07:45 PM EST Reads: 2,057
Dec. 27, 2014 04:00 PM EST Reads: 1,927
Dec. 27, 2014 02:00 PM EST Reads: 2,010
Dec. 27, 2014 12:45 PM EST Reads: 1,764
Dec. 27, 2014 12:30 PM EST Reads: 1,978